Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination

被引：8
作者：
Cisse, Hawa [1 ]
Vernet-Garnier, Veronique [2 ]
Hentzien, Maxime [1 ]
Bajolet, Odile [3 ]
Lebrun, Delphine [4 ]
Bonnet, Morgane [5 ]
Ohl, Xavier [6 ]
Diallo, Saidou [6 ]
Bani-Sadr, Firouze [1 ]
机构：
[1] Reims Teaching Hosp, Dept Internal Med & Infect Dis, Reims, France
[2] Reims Teaching Hosp, Dept Bacteriol, Reims, France
[3] Reims Teaching Hosp, Dept Hyg, Reims, France
[4] Manchester Hosp, Dept Internal Med & Infect Dis, Charleville Mezieres, France
[5] Reims Teaching Hosp, Dept Pharm, Reims, France
[6] Reims Teaching Hosp, Dept Orthopaed Surg, Reims, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2019年 / 54卷 / 02期
关键词：
Bone infection; Enterobacter spp; Enterobacter cloacae; Fluoroquinolone-cotrimoxazole combination; Fluoroquinolone; Cotrimoxazole; GRAM-NEGATIVE BACILLI; RISK-FACTORS; TRIMETHOPRIM; OSTEOMYELITIS; RIFAMPIN; THERAPY;
D O I：
10.1016/j.ijantimicag.2019.05.010
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Although the frequency of bone and joint infections caused by Enterobacter spp. is increasing, studies regarding the optimal antibiotic therapy are scarce. The objective of this retrospective study was to assess the clinical outcomes and safety of a fluoroquinolone-cotrimoxazole combination for the treatment of bone and joint infections caused by Enterobacter cloacae. Between 2010 and 2017, 30 patients with bone and joint infections caused by E. cloacae were treated with a fluoroquinolone-cotrimoxazole combination for 8-12 weeks. There were 26 cases (87%) of infection of an internal fixation device, two cases (6.6%) of pseudarthrosis with chronic osteomyelitis, and two cases (6.6%) of infection of knee and ankle prosthetic devices. The cure rate of the fluoroquinolone-cotrimoxazole combination was 80% by intention-to-treat analysis, with a mean follow-up of 29.3 +/- 19.1 months. The fluoroquinolone-cotrimoxazole combination for 8-12 weeks is effective for the treatment of bone and joint infections caused by E. cloacae. (C) 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码：245 / 248
页数：4
相关论文
共 50 条
  • [21] Management of Osteoarticular Infections Caused by Staphylococcus aureus Is Similar to That of Other Etiologies Analysis of 199 Staphylococcal Bone and Joint Infections
    Paakkonen, Markus
    Kallio, Pentti E.
    Kallio, Markku J. T.
    Peltola, Heikki
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (05) : 436 - 438
  • [22] Hypokalemia during antibiotic treatment for bone and joint infections
    Falcone C.
    Compostella L.
    Camardo A.
    Truong L.V.S.
    Centofanti F.
    European Journal of Orthopaedic Surgery & Traumatology, 2018, 28 (3) : 389 - 395
  • [23] Advancing the fight against bone and joint infections: a special issue in diagnostics and treatment
    Rupp, Markus
    Citak, Mustafa
    Sigmund, Irene Katharina
    FRONTIERS IN SURGERY, 2023, 10
  • [24] Early switch from intravenous to oral antibiotic treatment in bone and joint infections
    Sendi, Parham
    Lora-Tamayo, Jaime
    Cortes-Penfield, Nicolas W.
    Uckay, Ilker
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (09) : 1133 - 1138
  • [25] Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections
    Suh, Gina A.
    Ferry, Tristan
    Abdel, Matthew P.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 : S407 - S415
  • [26] Clinical Guidelines for the Antimicrobial Treatment of Bone and Joint Infections in Korea
    Lee J.-S.
    Lee J.
    Choi J.-P.
    Song J.-Y.
    Ha C.-W.
    Lee J.H.
    Yoo J.J.
    Yum J.-K.
    Oh H.-K.
    In Y.
    Lee H.-Y.
    INFECTION AND CHEMOTHERAPY, 2014, 46 (02) : 125 - 138
  • [27] Dalbavancin for the treatment of bone and joint infections: A meta-analysis
    Almangour, Thamer A.
    Alrasheed, Marwan A.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
  • [28] Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections
    Cooper, Christopher C.
    Stein, Gary E.
    Mitra, Subhashis
    Abubaker, Ahmed
    Havlichek, Daniel H.
    SURGICAL INFECTIONS, 2021, 22 (08) : 771 - 779
  • [29] A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
    Dimopoulou, Dimitra
    Mantadakis, Elpis
    Koutserimpas, Christos
    Samonis, George
    ANTIBIOTICS-BASEL, 2023, 12 (10):
  • [30] Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant-Related Infections
    Ceccarelli, Giancarlo
    Perciballi, Beatrice
    Russo, Alessandro
    Martini, Paolo
    Marchetti, Francesco
    Capparuccia, Marco Rivano
    Iaiani, Giancarlo
    Fabris, Silvia
    Ciccozzi, Massimo
    Villani, Ciro
    Venditti, Mario
    D'Ettorre, Gabriella
    De Meo, Daniele
    ANTIBIOTICS-BASEL, 2023, 12 (05):
12345